fig2
![The role of radiation therapy in the management of primary thymic epithelial neoplasms](https://image.oaes.cc/4c6742ad-720e-42bf-b28d-d8dbb7749966/5167.fig.2.jpg)
Figure 2. Patient who presented at age 74 with an unresectable thymic squamous cell carcinoma with disease in his left supraclavicular lymph nodes, his right level 2 and 4 lymph nodes and in the thymus [(A) PET-CT at diagnosis]. He was treated with definitive chemoradiation to a dose of 66 Gy in 33 fractions [(B) dose-volume histogram with structure set for D plan; (C) axial image of dose distribution at the level of the supraclavicular lymph nodes; (D) axial image of dose distribution at the level of the sternomanubrial joint; (E) axial image of dose distribution at the level of the pulmonary artery; (F) sagittal image of dose distribution] with weekly carboplatin and Taxol, followed by 2 additional cycles of carboplatin and Taxol.